Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Dec;54(12):1061-2.
doi: 10.1136/jnnp.54.12.1061.

Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation

R Ricciardi  1 , B Rossi, M Nicora, A Sghirlanzoni, A Muratorio
Affiliations

Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation

R Ricciardi et al. J Neurol Neurosurg Psychiatry. 1991 Dec.

Abstract

The effectiveness of intranasal neostigmine (9.3-13.8 mg) was tested in 20 subjects with myasthenia gravis, classified as Osserman grades 2A and 2B. In all cases the drug produced significant clinical and electromyographic improvement. No side effects were reported during the treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurol. 1988 Nov;235(8):449-53 - PubMed
    1. J Pharm Sci. 1987 Dec;76(12):876-9 - PubMed
    1. Brain Res. 1968 Aug 5;10(1):1-78 - PubMed
    1. Ann N Y Acad Sci. 1971 Sep 15;183:287-302 - PubMed
    1. Ann Neurol. 1986 Feb;19(2):192-4 - PubMed